This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Laryngology/ Speech/ Language Pathology  • Neoplasms of Head & Neck  • Radiation Therapy  • Alert me on articles by topic

Arch Otolaryngol Head Neck Surg. 2005;131:815-818.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Hypothesis: Concurrent platinum-based chemoradiotherapy (CRT) is the most appropriate first-line treatment for most T3 laryngeal carcinomas.

BACKGROUND

Prior to the Department of Veterans Affairs (VA) Laryngeal Cancer Study Group’s prospective randomized organ preservation trial,¹ the standard of care for most T3 laryngeal carcinomas was total laryngectomy (TL) and postoperative adjuvant radiotherapy. Along with the introduction of nonoperative organ-preserving treatment strategies came an extensive and ongoing debate on the most appropriate treatment for advanced laryngeal carcinoma. Both the VA laryngeal study¹ and subsequent European Organization for Research and Treatment of Cancer (EORTC) trial² for hypopharyngeal carcinoma demonstrated that neoadjuvant CRT, compared with TL and postoperative radiotherapy, allowed preservation of the larynx in 50% to 64% of patients without compromising survival. Neither of these studies included a radiotherapy-only arm, bringing into question the true role of neoadjuvant chemotherapy. This led to the Radiation Therapy Oncology Group (RTOG) 91-11 trial³ that compared radiation only . . . [Full Text of this Article]

PROS

CONS

BOTTOM LINE

AUTHOR INFORMATION

Danny J. Enepekides, MD
Author Affiliations: Departments of Otolaryngology–Head and Neck Surgery, UC Davis Medical Center, Sacramento, Calif, and Northern California VA Medical Center, Mather Field, Calif.

RELATED ARTICLES

Selecting From the Menu of Treatment Options for Locally Advanced Laryngeal Cancer
K. Thomas Robbins
Arch Otolaryngol Head Neck Surg. 2005;131(9):819.
EXTRACT | FULL TEXT  

Concurrent Chemoradiation as a Treatment Option for Advanced-Stage Laryngeal Cancers
Russell B. Smith
Arch Otolaryngol Head Neck Surg. 2005;131(9):820.
EXTRACT | FULL TEXT